AI Article Synopsis
- Real-time genomics using nanopore sequencing can quickly predict antibiotic resistance in clinical settings, which is crucial for timely treatment.
- Despite some accuracy concerns compared to traditional methods, this approach can accurately identify low-abundance resistance factors often missed by conventional diagnostics.
- The study highlights that real-time genomic analysis can greatly enhance clinical decision-making by revealing hidden resistance profiles, ultimately improving patient outcomes.
Article Abstract
Real-time genomics through nanopore sequencing holds the promise of fast antibiotic resistance prediction directly in the clinical setting. However, concerns about the accuracy of genomics-based resistance predictions persist, particularly when compared to traditional, clinically established diagnostic methods. Here, we leverage the case of a multi-drug resistant Klebsiella pneumoniae infection to demonstrate how real-time genomics can enhance the accuracy of antibiotic resistance profiling in complex infection scenarios. Our results show that unlike established diagnostics, nanopore sequencing data analysis can accurately detect low-abundance plasmid-mediated resistance, which often remains undetected by conventional methods. This capability has direct implications for clinical practice, where such "hidden" resistance profiles can critically influence treatment decisions. Consequently, the rapid, in situ application of real-time genomics holds significant promise for improving clinical decision-making and patient outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11214615 | PMC |
| http://dx.doi.org/10.1038/s41467-024-49851-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!